307 related articles for article (PubMed ID: 32390175)
1. Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
Cavallone D; Ricco G; Oliveri F; Colombatto P; Moriconi F; Coco B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
Aliment Pharmacol Ther; 2020 Jun; 51(12):1406-1416. PubMed ID: 32390175
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
[TBL] [Abstract][Full Text] [Related]
7. Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodríguez-Tajes S; Mas A; García-López M; Pérez-Del-Pulgar S; Sánchez-Tapias JM; Forns X
Aliment Pharmacol Ther; 2018 May; 47(10):1397-1408. PubMed ID: 29577350
[TBL] [Abstract][Full Text] [Related]
8. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
Tseng TC; Liu CJ; Yang WT; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028
[TBL] [Abstract][Full Text] [Related]
10. Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.
Matsumoto A; Tanaka E; Morita S; Yoshizawa K; Umemura T; Joshita S
J Gastroenterol; 2012 Sep; 47(9):1006-13. PubMed ID: 22370816
[TBL] [Abstract][Full Text] [Related]
11. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
Fung J; Seto WK; Wong DK; Lai CL; Yuen MF
Liver Int; 2015 Mar; 35(3):854-9. PubMed ID: 24840542
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
14. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
[TBL] [Abstract][Full Text] [Related]
15. Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection.
Tseng TC; Liu CJ; Chen CL; Yang WT; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Aliment Pharmacol Ther; 2015 May; 41(10):949-60. PubMed ID: 25809540
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
Su TH; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen CL; Chen PJ; Kao JH; Chen DS
PLoS One; 2013; 8(2):e55916. PubMed ID: 23437072
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
Atay AE; Seven G; Yalcin K; Pasa S; Degertekin H
J Int Med Res; 2012; 40(5):1891-6. PubMed ID: 23206472
[TBL] [Abstract][Full Text] [Related]
18. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg).
Cheng J; Dai Y; Yan L; Zhou H; Xu X; Sun C; Wang Z
Med Sci Monit; 2018 Mar; 24():1826-1835. PubMed ID: 29593208
[TBL] [Abstract][Full Text] [Related]
20. New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.
Zoulim F; Mimms L; Floreani M; Pichoud C; Chemin I; Kay A; Vitvitski L; Trepo C
J Clin Microbiol; 1992 May; 30(5):1111-9. PubMed ID: 1583107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
